is bpc 157 a synthetic peptide | Gastric Pentadecapeptide BPC-157 Peptide Therapy | Doctors

The lead time for this product may be several months

This makes it more challenging to determine both efficacy and safety

Consequently, with BPC 157 therapy, the clear counteraction, which occurred in the rats which have the permanent occlusion of the superior sagittal sinus, as before in the BuddChiari syndrome-rats or Pringle maneuver ischemia, reperfusion-rats [26,27] and other venous occlusion studies [20,21,22,23,24,25,26,27], may suggest possible BPC 157 therapy effect in patients as well

10.1152/physrev.00050.2017 179 SyvnenS.LindheO.PalnerM.KornumB

These findings suggest that research into the therapeutic modulation of FOXO4 activity, such as through the use of the synthetic peptide FOXO4-DRI, could provide insight into the heart's natural protective mechanisms and degenerative changes associated with aging